CLINICAL RESEARCH: HEART FAILURE
Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge
Javed Butler, MD, MPH, FACC*  ||,*,
Patrick G. Arbogast, PhD ,
James Daugherty, MS,
Manoj K. Jain, MD, MPH||,
Wayne A. Ray, PhD and
Marie R. Griffin, MD, MPH
* Cardiology Division, Vanderbilt University, Nashville, Tennessee, USA
Department of Preventive Medicine, Vanderbilt University, Nashville, Tennessee, USA
Center for Education and Research in Therapeutics, Vanderbilt University, Nashville, Tennessee, USA
Geriatrics Research, Education, and Clinical Center, Nashville VAMC, Nashville, Tennessee, USA
|| Centers for Healthcare Quality Inc., Memphis, Tennessee, USA
Manuscript received November 24, 2003;
revised manuscript received January 5, 2004,
accepted January 13, 2004.
* Reprint requests and correspondence: Dr. Javed Butler, Cardiology Division, 383-PRB, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.
javed.butler{at}vanderbilt.edu
OBJECTIVES: This study was designed to assess outpatient angiotensin-converting enzyme inhibitor (ACEI) use after heart failure (HF) hospitalization.
BACKGROUND: Assuring therapy with ACEIs at discharge after HF hospitalization is a key Medicare quality measure. The benefits of such quality improvement attempts will be limited if therapy is not continued long-term.
METHODS: To assess the factors associated with filling an ACEI prescription in the 30 days postdischarge and the proportion of patients who filled such prescriptions subsequently up to 365 days postdischarge, we studied 219 patients with depressed ejection fraction (EF) specifically and 960 HF patients in general.
RESULTS: Sixty-seven percent of patients with depressed EF and 55% of the total cohort were discharged with ACEIs. Overall 81.2%/77.1% (depressed EF/total cohort) of survivors discharged with ACEIs had filled a prescription by 30 days postdischarge; only 66.3%/63.3% were current users at 365 days. In contrast, for patients with no discharge order for ACEIs, only 12.7%/12.0% (depressed EF/total cohort) had filled such a prescription by 30 days and 12.5%/18.8% were current users at 365 days postdischarge. Patients with a discharge order for ACEIs were more likely to fill a prescription within 30 days postdischarge (hazard ratio 10.93, 95% confidence interval 5.28, 22.61, for patients with depressed EF).
CONCLUSIONS: For patients with HF who are discharged while taking ACEIs, there is a significant decline in use after discharge. Patients not discharged with ACEIs are unlikely to be started as outpatients. Quality improvement efforts therefore need to be focused on both discharge planning and outpatient care.
|
Abbreviations and Acronyms
| | ACEI | = angiotensin-converting enzyme inhibitor | | ARB | = angiotensin receptor blocker | | CMS | = Centers for Medicare and Medicaid Services | | EF | = ejection fraction | | HF | = heart failure | | HR | = hazard ratio | | JCAHO | = Joint Commission for Accreditation of Healthcare Organizations |
|
This article has been cited by other articles:
|
|
|
|
 
C. Adamopoulos, A. Ahmed, R. Fay, M. Angioi, G. Filippatos, J. Vincent, B. Pitt, F. Zannad, and the EPHESUS Investigators
Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial
Eur J Heart Fail,
November 1, 2009;
11(11):
1099 - 1105.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Riegel, D. K. Moser, S. D. Anker, L. J. Appel, S. B. Dunbar, K. L. Grady, M. Z. Gurvitz, E. P. Havranek, C. S. Lee, J. Lindenfeld, et al.
State of the Science: Promoting Self-Care in Persons With Heart Failure: A Scientific Statement From the American Heart Association
Circulation,
September 22, 2009;
120(12):
1141 - 1163.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Flaherty, J. J. Bax, L. De Luca, J. S. Rossi, C. J. Davidson, G. Filippatos, P. P. Liu, M. A. Konstam, B. Greenberg, M. R. Mehra, et al.
Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment.
J. Am. Coll. Cardiol.,
January 20, 2009;
53(3):
254 - 263.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Miki, M. E. Oetgen, J. Kirk, K. L. Insogna, and D. M. Lindskog
Orthopaedic Management Improves the Rate of Early Osteoporosis Treatment After Hip Fracture. A Randomized Clinical Trial
J. Bone Joint Surg. Am.,
November 1, 2008;
90(11):
2346 - 2353.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. T. Ko, H. M. Krumholz, Y. Wang, J. M. Foody, F. A. Masoudi, E. P. Havranek, J. J. You, D. A. Alter, T. A. Stukel, A. M. Newman, et al.
Regional Differences in Process of Care and Outcomes for Older Acute Myocardial Infarction Patients in the United States and Ontario, Canada
Circulation,
January 16, 2007;
115(2):
196 - 203.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Butler, J. B. Young, W. T. Abraham, R. C. Bourge, K. F. Adams Jr, R. Clare, C. O'Connor, and for the ESCAPE Investigators
Beta-Blocker Use and Outcomes Among Hospitalized Heart Failure Patients
J. Am. Coll. Cardiol.,
June 20, 2006;
47(12):
2462 - 2469.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. T. Ko, J. V. Tu, F. A. Masoudi, Y. Wang, E. P. Havranek, S. S. Rathore, A. M. Newman, L. R. Donovan, D. S. Lee, J. M. Foody, et al.
Quality of Care and Outcomes of Older Patients With Heart Failure Hospitalized in the United States and Canada
Arch Intern Med,
November 28, 2005;
165(21):
2486 - 2492.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. H Skrepnek, J. Abarca, D. C Malone, E. P Armstrong, F. M Shirazi, and R. L Woosley
Incremental Effects of Concurrent Pharmacotherapeutic Regimens for Heart Failure on Hospitalizations and Costs
Ann. Pharmacother.,
November 1, 2005;
39(11):
1785 - 1791.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. M. Krumholz
The Year in Epidemiology, Health Services, and Outcomes Research
J. Am. Coll. Cardiol.,
October 4, 2005;
46(7):
1362 - 1370.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. McMurray, A. Cohen-Solal, R. Dietz, E. Eichhorn, L. Erhardt, F.D. R. Hobbs, H. Krum, A. Maggioni, R. S. McKelvie, I. L. Pina, et al.
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice
Eur J Heart Fail,
August 1, 2005;
7(5):
710 - 721.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. O. Akosah, A. M. Schaper, L. M. Haus, M. A. Mathiason, S. I. Barnhart, and V. L. McHugh
Improving Outcomes in Heart Failure in the Community: Long-term Survival Benefit of a Disease-Management Program
Chest,
June 1, 2005;
127(6):
2042 - 2048.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y.W. Lew, J. Narula, D. Sahn, et al.
Highlights of the year in JACC 2004
J. Am. Coll. Cardiol.,
January 4, 2005;
45(1):
137 - 153.
[Full Text]
[PDF]
|
|
|
|
